BackNewAmsterdam Pharma Company NV - Warrants (15/11/2027) Overview

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) Receivables

NewAmsterdam Pharma Company NV - Warrants (15/11/2027)'s receivables is $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer average

Loading

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) Receivables History

Loading

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) vs. peers: Receivables Comparison

Loading

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMSW) FAQ

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMSW) currently reports a receivables of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore NewAmsterdam Pharma Company NV - Warrants (15/11/2027)'s receivables history and peer comparisons.

NewAmsterdam Pharma Company NV - Warrants (15/11/2027)'s receivables changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) reported $0 in receivables as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NewAmsterdam Pharma Company NV - Warrants (15/11/2027), and consider following NAMSW for alerts when major investors trade the stock.